Hungarian Chemium Biotechnológia winds up R&D project
Hungary's Chemium Biotechnológia has completed a HUF 220 mln project for the development of a device for the diagnosis of respiratory pathogens, the company informed MTI.
The company is expected to start seeking permits for the device in the fall of this year. Negotiations have already started on the sale of the technology and its possible domestic production.
The present project of Chemium Biotechnológia was partially car based on a HUF 150 mln grant. The company employing 9 people has generated revenue of almost HUF 100 mln.
MOL Shareholders Approve Dividend of Around HUF 250/Share
Gov't Awards HUF 6.5 bln of Subsidies to SMEs in Underdevelo...
Hungary's Largest ESG Consultancy Formed by Merger of EY, De...
Liz & Chain Rooftop Bar Debuts Sustainable Cocktails
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
